CanCan Diagnostics

Curated by Signal

Provider of cancer diagnosis and monitoring solutions for pets

Overview

Provider of cancer diagnosis and monitoring solutions for pets. It offers minimally invasive test called K9-LiquiDX, which uses liquid biopsy technology to detect and track cancer in dogs, and early detection and monitoring of canine cancer.

Key facts

Founded: 2023
Headquarters: Edinburgh, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Hemp Well
Provider of hemp-based supplements
Health TechnologyYork, United Kingdom
Priory Connect
Digital telehealth solution for therapists
Health TechnologyLondon, United Kingdom
VSR
Provider of cloud-based fertility evaluation of bulls and rams and reporting software system
Health TechnologyUnited Kingdom

About CanCan Diagnostics

What does CanCan Diagnostics do?

Provider of cancer diagnosis and monitoring solutions for pets.

Where is CanCan Diagnostics headquartered?

CanCan Diagnostics is headquartered in Edinburgh, United Kingdom.

When was CanCan Diagnostics founded?

CanCan Diagnostics was founded in 2023.

Which sector is CanCan Diagnostics in?

CanCan Diagnostics operates in Health Technology.

Who are CanCan Diagnostics's competitors?

Companies similar to CanCan Diagnostics include Hemp Well, Priory Connect, and VSR.